Ageing Research Reviews

Papers
(The H4-Index of Ageing Research Reviews is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Board382
Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies366
Comparison between frail and non-frail older adults’ gut microbiota: A systematic review and meta-analysis317
Targeted microbiota dysbiosis repair: An important approach to health management after spinal cord injury273
Medication reviews in hospitalised patients for reduced hospital readmission and mortality. Systematic review, meta-analysis and meta-regression of RCTs219
Metabolic dysfunction contributes to mood disorders after traumatic brain injury213
Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems210
From text to insight: A natural language processing-based analysis of burst and research trends in HER2-low breast cancer patients208
Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review202
Exploring the conceptual framework and measurement model of intrinsic capacity defined by the World Health Organization: A scoping review185
Curcumin nanoformulations to combat aging-related diseases181
From biological aging to functional decline: Insights into chronic inflammation and intrinsic capacity178
Adult-onset hearing loss and incident cognitive impairment and dementia – A systematic review and meta-analysis of cohort studies166
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention164
The roles of the Hippo-YAP signalling pathway in Cartilage and Osteoarthritis163
Modulation of cholesterol metabolism with Phytoremedies in Alzheimer’s disease: A comprehensive review141
Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo 31P-MRS studies141
Lactylation modification in cardio-cerebral diseases: A state-of-the-art review139
Precision neurology134
Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions133
Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities133
Bridging geriatric medicine, clinical pharmacology and ageing biology to understand and improve outcomes of medicines in old age and frailty129
DNA methylation in genes associated with the evolution of ageing and disease: A critical review127
Editorial Board126
Editorial Board126
Psychometric characteristics of comprehensive geriatric assessments (CGAs) for long-term care facilities and community care: A systematic review126
Editorial Board124
Editorial Board120
Editorial Board118
Pyroptosis: Mechanisms and links with diabetic cardiomyopathy118
Association of F2-isoprostane levels with Alzheimer’s disease in observational studies: A systematic review and meta-analysis117
Editorial Board116
Editorial Board110
Reply to “Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines”108
Determining the cortical, spinal and muscular adaptations to strength-training in older adults: A systematic review and meta-analysis107
COVID-19 mortality as a fingerprint of biological age105
The protein inputs of an ultra-predictive aging clock represent viable anti-aging drug targets104
Sex difference, proteostasis and mitochondrial function impact stroke-related sarcopenia—A systematic review and meta-analysis103
Pangenomics: A new era in the field of neurodegenerative diseases97
Lifestyle strategies to promote proteostasis and reduce the risk of Alzheimer’s disease and other proteinopathies96
Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease95
Sarcopenia defined by the psoas muscle mass or quality is associated with poor survival in patients with aortic aneurysm undergoing surgery: A meta-analysis95
Restoring the oxidative balance in age-related diseases – An approach in glaucoma94
Constituent isoflavones of Puerariae radix as a potential neuroprotector in cognitive impairment: Evidence from preclinical studies94
Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury93
Genetic aberration analysis of mitochondrial respiratory complex I implications in the development of neurological disorders and their clinical significance92
Gut microbiome and Alzheimer’s disease: What we know and what remains to be explored92
The functions of IRE1α in neurodegenerative diseases: Beyond ER stress91
Neolignans in Magnolia officinalis as natural anti-Alzheimer’s disease agents: A systematic review90
To breathe or not to breathe: Understanding how oxygen sensing contributes to age-related phenotypes90
Beyond cardiovascular risk: Implications of Familial hypercholesterolemia on cognition and brain function88
Risk of seizures and subclinical epileptiform activity in patients with dementia: A systematic review and meta-analysis87
The retina: A window in which to view the pathogenesis of Alzheimer’s disease87
Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease85
Mechanism and therapeutic targets of the involvement of a novel lysosomal proton channel TMEM175 in Parkinson's disease82
Frailty in rodents: Models, underlying mechanisms, and management82
Frailty and pain, human studies and animal models82
Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases82
Energy metabolism and frailty: The potential role of exercise-induced myokines – A narrative review81
The unique neuropathological vulnerability of the human brain to aging80
Bio-enhanced fraction from Clitoria ternatea root extract ameliorates cognitive functions and in vivo hippocampal neuroplasticity in chronic cerebral hypoperfusion rat model80
Therapeutic potential of lipid nanosystems for the treatment of Parkinson’s disease80
Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways79
Universal masking during COVID-19 outbreaks in aged care settings: A systematic review and meta-analysis79
Calprotectin in Parkinsonian disease: Anticipation and dedication78
Spatial omics: An innovative frontier in aging research76
Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects76
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors75
The underlying roles and neurobiological mechanisms of music-based intervention in Alzheimer's disease: A comprehensive review74
Prevalence of radicular neuropathic pain in idiopathic Parkinson’s disease: A systematic review and meta-analysis73
Advances in clinical application of lipidomics in healthy ageing and healthy longevity medicine71
0.19506597518921